ILC2-derived IL-9 promotes eosinophil-mediated antitumor activity
- 23 October 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (124) , eadz0989
Abstract
Innate lymphoid cells (ILCs) regulate tissue immunity, yet their roles in tumor control remain incompletely understood. Here, we combined analyses of human sequencing datasets with genetic ablation mouse models and adoptive transfer experiments to identify that glucocorticoid-induced tumor necrosis factor receptor (GITR) engagement on tumor-infiltrating group 2 ILCs (ILC2s) induced activating transcription factor 3 (ATF3) and robust interleukin-9 (IL-9) production, exceeding the modest coinduction of IL-5 and IL-13. ILC2-derived IL-9 promoted intratumoral eosinophil accumulation by enhancing survival, tissue retention, and cytotoxicity through tumor-induced IL-9 receptor expression. Eosinophil ablation abolished GITR-mediated tumor control, whereas adoptive eosinophil transfer restored it. This IL-9–eosinophil pathway suppressed tumor growth in the absence of adaptive lymphocytes. In human datasets, IL-9 and eosinophil signatures were associated with favorable prognosis in melanoma and lung adenocarcinoma. These findings define an innate pathway linking ILC2s to eosinophil-mediated tumor immunity and support GITR agonism as a therapeutic strategy.Keywords
Funding Information
- National Research Foundation of Korea (2022R1A2C3007730, RS-2023-00217798)
- National Research Foundation of Korea (RS-2023-00274029)
This publication has 71 references indexed in Scilit:
- Single-cell RNA-sequencing of circulating eosinophils from asthma patients reveals an inflammatory signatureiScience, 2025
- Single cell RNA sequencing of human eosinophils from nasal polyps reveals eosinophil heterogeneity in chronic rhinosinusitis tissueJournal of Allergy and Clinical Immunology, 2024
- Single-cell proteomics and transcriptomics capture eosinophil development and identify the role of IL-5 in their lineage transit amplificationImmunity, 2024
- Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell deathCell, 2024
- IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancerCancer Cell, 2022
- GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T CellsCellular and Molecular Gastroenterology and Hepatology, 2022
- Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancerCancer Cell, 2022
- Innate Lymphoid Cells: 10 Years OnCell, 2018
- GITR cosignal in ILC2s controls allergic lung inflammationJournal of Allergy and Clinical Immunology, 2018
- Checkpoint blockade for cancer therapy: revitalizing a suppressed immune systemTrends in Molecular Medicine, 2015